News

John “Jack” S. Linehan, a lawyer at Epstein Becker Green, is featured in the first part of a two-part video series on copay accumulators and maximizers.

States are moving to curb copay accumulators as federal government pulls back from regulation.

Emphasizing best practices and a healthy culture rather than focusing narrowly on compensation will help medical groups thrive.

After positive Phase 3 trial results, Karyopharm Therapeutics expects FDA to clear Xpovio.

The test is for patients to use at home, with a prescription, to detect both COVID-19 and influenza A and B.

Women are disproportionately affected by heart failure after heart attacks, according to a Canadian study.

Zients, who served as director of the National Economic Council under Barack Obama, would come to the post with a background in business and technology, rather than a traditional healthcare portfolio.

Biden is also ready to announce that MGH infectious disease chief Rochelle Walensky is his pick for top job at the CDC

Some leading hospitals have already started experimenting with deep learning based AI that applies most directly to medical imaging. In a few years, we will be taking many more uses of AI for granted. How does the healthcare industry get from here to there?

If the boom in new C-suite titles in healthcare — such as chief experience officer, chief growth officer, and chief analytics officer — “reflect new priorities and cultural shifts” inside organizations, what new titles should we be on the lookout for in the year ahead?

The subsidiary, called Vivid Clear Rx, will provide PBM services to help the company's 88,000 employees better manage their healthcare costs.

CVS and Walgreens are poised to vaccinate residents and employees of long-term care facilities. Dentists and optometrists are angling to be among the healthcare professionals who could administer the COVID-19 vaccines.

As the world remains battling the coronavirus pandemic, there are still significant and unmet needs for those fighting chronic conditions and disorders like opioid use disorder (OUD).

COVID-19 pandemic may present an opportunity to hit a reset button on American healthcare that could winnow out unnecessary, wasteful services and prescriptions.

New Mexico Gov. Michelle Lujan Grisham and former Surgeon General Vivek Murthy appear to be the frontrunners for HHS secretary in the Biden administration.

FDA okayed the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen positive lesions in men with prostate cancer.

Nearly two-thirds of U.S. patients are likely to switch to a new healthcare provider if their current health provider doesn’t meet their expectations for managing COVID-19 concerns.

The drug is the first FDA-approved therapy for these rare genetic diseases.

In a time of lockdowns and concerted efforts to avoid exposure to COVID-19, telehealth is not only the hottest topic in healthcare, but also a boon to providers attempting to treat behavioral health patients in a holistic and cost-effective way.

The continuous battle in cancer research has unfortunately fallen a bit to the backseat due to healthcare's main focus on beating COVID-19 wildfires. To bring its needed attention back up on the ladder, Marie Lamont, president and COO of Inteliquet, a clinical trial software company, shares what took place in the drop of oncology-related activity and what can be done to improve.

Customer experience is everything, especially for healthcare businesses. However, there seems to be a gap between healthcare providers and their consumers.

FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.

For medical professionals, COVID-19 has amplified the importance of following the evidence.

Results of APOLLO and REACH3 trials are scheduled for presentation at the American Society of Hematology meeting next month are expected to garner attention.

Public health policies and treatment advances have made a difference.

Radiation oncologists across the country met virtually with members of Congress last week to urge lawmakers to pass legislation that will safeguard access to high-quality, value-based healthcare for people with cancer.

The second of a two-part story on 10 takeaways about the telehealth boom. The COVID-19 pandemic has been a bumpy ride in the U.S., featuring one controversy after another. One of the few areas of agreement is that the widespread adoption of telehealth amid the pandemic has been, by and large, a positive development.

Applying lessons from behavioral economics, health systems are using “nudges” to influence the choices clinicians make.